Estimated Prevalence of Post-intensive Care Cognitive Impairment at Short-term and Long-term Follow-ups: a Proportional Meta-analysis of Observational Studies

Overview

Journal Ann Intensive Care

Date 2025 Jan 10

PMID 39792310

Authors

Mu-Hsing Ho

Yi-Wei Lee

Lizhen Wang

Affiliations

Soon will be listed here.

Abstract

Objective: Evidence of the overall estimated prevalence of post-intensive care cognitive impairment among critically ill survivors discharged from intensive care units at short-term and long-term follow-ups is lacking. This study aimed to estimate the prevalence of the post-intensive care cognitive impairment at time to < 1 month, 1 to 3 month(s), 4 to 6 months, 7-12 months, and > 12 months discharged from intensive care units.

Methods: Electronic databases including PubMed, Cochrane Library, EMBASE, CINAHL Plus, Web of Science, and PsycINFO via ProQuest were searched from inception through July 2024. Studies that reported on cognitive impairment among patients discharged from intensive care units with valid measures were included. Data extraction and risk of bias assessment were performed independently for all included studies according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses reporting guidelines. Newcastle-Ottawa Scale was used to measure risk of bias. Data on cognitive impairment prevalence were pooled using a random-effects model. The primary outcome was pooled estimated proportions of prevalence of the post-intensive care cognitive impairment.

Results: In total, 58 studies involving 347,940 patients were included. The pooled post-intensive care cognitive impairment prevalence rates at the follow-up timepoints < 1 month, 1-3 month(s), 4-6 months, 7-12 months, > 12 months were 49.8% [95% Prediction Interval (PI), 39.9%-59.7%, n = 19], 45.1% (95% PI, 34.8%-55.5%, n = 23), 47.9% (95% PI, 35.9%-60.0%, n = 16), 28.3% (95% PI, 19.9%-37.6%, n = 19), and 30.4% (95% PI, 18.4%-43.9%, n = 7), respectively. Subgroup analysis showed that significant differences of the prevalence rates between continents and study designs were observed.

Conclusions: The prevalence rates of post-intensive care cognitive impairment differed at different follow-up timepoints. The rates were highest within the first three months of follow-up, with a pooled prevalence of 49.8% at less than one month, 45.1% at one to three months, and 47.9% at three to six months. No significant differences in prevalence rates between studies that only included coronavirus disease 2019 survivors. These fundings highlight the need for further research to develop targeted interventions to prevent or manage cognitive impairment at short-term and long-term follow-ups.

References

Baldwin M, Pollack L, Friedman R, Norris S, Javaid A, ODonnell M . Frailty subtypes and recovery in older survivors of acute respiratory failure: a pilot study. Thorax. 2020; 76(4):350-359. PMC: 8187474. DOI: 10.1136/thoraxjnl-2020-214998. View

Akinosoglou K, Schinas G, Almyroudi M, Gogos C, Dimopoulos G . The impact of age on intensive care. Ageing Res Rev. 2022; 84:101832. PMC: 9769029. DOI: 10.1016/j.arr.2022.101832. View

Chung C, Yoo H, Park J, Ryu S . Cognitive Impairment and Psychological Distress at Discharge from Intensive Care Unit. Psychiatry Investig. 2017; 14(3):376-379. PMC: 5440442. DOI: 10.4306/pi.2017.14.3.376. View

Jaquet P, Legouy C, Le Fevre L, Grinea A, Sinnah F, Franchineau G . Neurologic Outcomes of Survivors of COVID-19-Associated Acute Respiratory Distress Syndrome Requiring Intubation. Crit Care Med. 2022; 50(8):e674-e682. PMC: 9275804. DOI: 10.1097/CCM.0000000000005500. View

Maley J, Brewster I, Mayoral I, Siruckova R, Adams S, McGraw K . Resilience in Survivors of Critical Illness in the Context of the Survivors' Experience and Recovery. Ann Am Thorac Soc. 2016; 13(8):1351-60. PMC: 5021076. DOI: 10.1513/AnnalsATS.201511-782OC. View

Vincent A, Beck K, Thommen E, Widmer M, Becker C, Loretz N . Post-intensive care syndrome in out-of-hospital cardiac arrest patients: A prospective observational cohort study. PLoS One. 2022; 17(10):e0276011. PMC: 9565684. DOI: 10.1371/journal.pone.0276011. View

Bottom-Tanzer S, Poyant J, Louzada M, Abela D, Boudouvas A, Poon E . Longitudinal study evaluating post-ICU syndrome differences between acute care surgery and trauma SICU survivors. J Trauma Acute Care Surg. 2023; 95(6):893-898. DOI: 10.1097/TA.0000000000003977. View

Sturgill J, Mayer K, Kalema A, Dave K, Mora S, Kalantar A . Post-intensive care syndrome and pulmonary fibrosis in patients surviving ARDS-pneumonia of COVID-19 and non-COVID-19 etiologies. Sci Rep. 2023; 13(1):6554. PMC: 10119831. DOI: 10.1038/s41598-023-32699-x. View

Martinez E, Aguilera C, Marquez D, Ziegler G, Plumet J, Tschopp L . Post intensive care syndrome in survivors of COVID-19 who required mechanical ventilation during the third wave of the pandemic: A prospective study. Heart Lung. 2023; 62:72-80. PMC: 10277848. DOI: 10.1016/j.hrtlng.2023.06.021. View

10.

Martillo M, Dangayach N, Tabacof L, Spielman L, Dams-OConnor K, Chan C . Postintensive Care Syndrome in Survivors of Critical Illness Related to Coronavirus Disease 2019: Cohort Study From a New York City Critical Care Recovery Clinic. Crit Care Med. 2021; 49(9):1427-1438. DOI: 10.1097/CCM.0000000000005014. View

11.

Mitchell M, Shum D, Mihala G, Murfield J, Aitken L . Long-term cognitive impairment and delirium in intensive care: A prospective cohort study. Aust Crit Care. 2017; 31(4):204-211. DOI: 10.1016/j.aucc.2017.07.002. View

12.

Duggan M, Wang L, Wilson J, Dittus R, Wesley Ely E, Jackson J . The relationship between executive dysfunction, depression, and mental health-related quality of life in survivors of critical illness: Results from the BRAIN-ICU investigation. J Crit Care. 2016; 37:72-79. PMC: 5240988. DOI: 10.1016/j.jcrc.2016.08.023. View

13.

Abate S, Ali S, Mantfardo B, Basu B . Rate of Intensive Care Unit admission and outcomes among patients with coronavirus: A systematic review and Meta-analysis. PLoS One. 2020; 15(7):e0235653. PMC: 7351172. DOI: 10.1371/journal.pone.0235653. View

14.

Carenzo L, Zini L, Mercalli C, Stomeo N, Milani A, Amato K . Health related quality of life, physical function, and cognitive performance in mechanically ventilated COVID-19 patients: A long term follow-up study. J Crit Care. 2024; 82:154773. DOI: 10.1016/j.jcrc.2024.154773. View

15.

Higgins J, Thompson S . Quantifying heterogeneity in a meta-analysis. Stat Med. 2002; 21(11):1539-58. DOI: 10.1002/sim.1186. View

16.

Premraj L, Kannapadi N, Briggs J, Seal S, Battaglini D, Fanning J . Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta-analysis. J Neurol Sci. 2022; 434:120162. PMC: 8798975. DOI: 10.1016/j.jns.2022.120162. View

17.

Lee M, Kang J, Jeong Y . Risk factors for post-intensive care syndrome: A systematic review and meta-analysis. Aust Crit Care. 2019; 33(3):287-294. DOI: 10.1016/j.aucc.2019.10.004. View

18.

Bulic D, Bennett M, Georgousopoulou E, Shehabi Y, Pham T, Looi J . Cognitive and psychosocial outcomes of mechanically ventilated intensive care patients with and without delirium. Ann Intensive Care. 2020; 10(1):104. PMC: 7399009. DOI: 10.1186/s13613-020-00723-2. View

19.

Mart M, Semler M, Jenkins C, Wang G, Casey J, Wesley Ely E . Oxygen-Saturation Targets and Cognitive and Functional Outcomes in Mechanically Ventilated Adults. Am J Respir Crit Care Med. 2024; 209(7):861-870. PMC: 10995564. DOI: 10.1164/rccm.202310-1826OC. View

20.

Austin T, Thomas M, Lu M, Hodges C, Darowski E, Bergmans R . Meta-analysis of Cognitive Function Following Non-severe SARS-CoV-2 Infection. Neuropsychol Rev. 2024; . DOI: 10.1007/s11065-024-09642-6. View